Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BGM Group Ltd.

BGMNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.05
$0.01(0.96%)
U.S. Market opens in 13h 53m

BGM Group Ltd. Fundamental Analysis

BGM Group Ltd. (BGM) shows weak financial fundamentals with a PE ratio of -17.62, profit margin of -6.02%, and ROE of -1.27%. The company generates $0.2B in annual revenue with weak year-over-year growth of -45.99%.

Key Strengths

Cash Position47.66%
PEG Ratio-0.18
Current Ratio1.82

Areas of Concern

ROE-1.27%
Operating Margin-15.64%
We analyze BGM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -23.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-23.1/100

We analyze BGM's fundamental strength across five key dimensions:

Efficiency Score

Weak

BGM struggles to generate sufficient returns from assets.

ROA > 10%
-0.83%

Valuation Score

Excellent

BGM trades at attractive valuation levels.

PE < 25
-17.62
PEG Ratio < 2
-0.18

Growth Score

Moderate

BGM shows steady but slowing expansion.

Revenue Growth > 5%
-45.99%
EPS Growth > 10%
81.48%

Financial Health Score

Excellent

BGM maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
1.82

Profitability Score

Weak

BGM struggles to sustain strong margins.

ROE > 15%
-126.96%
Net Margin ≥ 15%
-6.02%
Positive Free Cash Flow
No

Key Financial Metrics

Is BGM Expensive or Cheap?

P/E Ratio

BGM trades at -17.62 times earnings. This suggests potential undervaluation.

-17.62

PEG Ratio

When adjusting for growth, BGM's PEG of -0.18 indicates potential undervaluation.

-0.18

Price to Book

The market values BGM Group Ltd. at 0.17 times its book value. This may indicate undervaluation.

0.17

EV/EBITDA

Enterprise value stands at -30.96 times EBITDA. This is generally considered low.

-30.96

How Well Does BGM Make Money?

Net Profit Margin

For every $100 in sales, BGM Group Ltd. keeps $-6.02 as profit after all expenses.

-6.02%

Operating Margin

Core operations generate -15.64 in profit for every $100 in revenue, before interest and taxes.

-15.64%

ROE

Management delivers $-1.27 in profit for every $100 of shareholder equity.

-1.27%

ROA

BGM Group Ltd. generates $-0.83 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.83%

Following the Money - Real Cash Generation

Operating Cash Flow

BGM Group Ltd. generates limited operating cash flow of $-29.09M, signaling weaker underlying cash strength.

$-29.09M

Free Cash Flow

BGM Group Ltd. generates weak or negative free cash flow of $-38.78M, restricting financial flexibility.

$-38.78M

FCF Per Share

Each share generates $-0.19 in free cash annually.

$-0.19

FCF Yield

BGM converts -3.11% of its market value into free cash.

-3.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-17.62

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.18

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.010

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.82

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How BGM Stacks Against Its Sector Peers

MetricBGM ValueSector AveragePerformance
P/E Ratio-17.6229.28 Better (Cheaper)
ROE-1.27%820.00% Weak
Net Margin-6.02%-19743.00% (disorted) Weak
Debt/Equity0.010.26 Strong (Low Leverage)
Current Ratio1.824.69 Neutral
ROA-0.83%-17807.00% (disorted) Weak

BGM outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews BGM Group Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-47.26%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-126.21%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

190.86%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ